Pure Global
NCT04605874

Cigar Packaging Study

STUDY 3: A Multidisciplinary Examination of the Effects of Cigarillo Package Quantity on Consumption, Purchase Intentions, Risk Perceptions, Use and Exposure
Andrew Strasser·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking
Drug/Device/Intervention
Package Quantity (cigarillos)
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Andrew Strasser
Funder
Abramson Cancer Center of the University of Pennsylvania
Location
Philadelphia, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 05, 2020
End date
Jan 01, 2023
Enrollment
85 participants
Primary outcome

Daily Cigarillo Consumption,Smoking Topography,Total Nicotine Equivalents,Total NNAL

Summary

The purpose of this study is to examine the effect of number of cigarillos per package on use
 behaviors, intensity of use and biomarkers of exposure.

ICD-10 classifications
Tobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco : harmful useDrug use
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04605874
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04605874 through Pure Global AI's free database. This phase not specified trial is sponsored by Andrew Strasser and is currently Recruiting. The study focuses on Smoking. Target enrollment is 85 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.